Clinical Trial: A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: Score of the Corneal conjunctival staining

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: September 20, 2012
Date Started:
Date Completion:
Last Updated: May 29, 2014
Last Verified: May 2014